METTL3 and non-small cell lung carcinoma: In general, miR-4443 can reduce the expression of METTL3 at the protein level, thereby increasing the expression of FSP1, and regulate the sensitivity of NSCLC cells to cisplatin by regulating the ferroptosis pathway.